Sector
HealthcareOpen
₹17.93Prev. Close
₹17.58Turnover(Lac.)
₹17.21Day's High
₹17.93Day's Low
₹17.9352 Week's High
₹28.952 Week's Low
₹9.8Book Value
₹22.97Face Value
₹10Mkt Cap (₹ Cr.)
7.77P/E
18.68EPS
0.96Divi. Yield
025 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
18 Sep 2024
12:00 AM
AGM
Announcement Date: 18 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 4.33 | 4.33 | 4.33 | 4.33 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 5.21 | 4.59 | 6.15 | 5.22 |
Net Worth | 9.54 | 8.92 | 10.48 | 9.55 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 9.77 | 6.1 | 5.26 | 2.78 |
yoy growth (%) | 60.22 | 16.02 | 88.81 | |
Raw materials | -3.6 | -1.14 | -0.6 | -0.62 |
As % of sales | 36.87 | 18.77 | 11.51 | 22.44 |
Employee costs | -0.68 | -0.86 | -0.94 | -0.49 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1.37 | 0.66 | 0.71 | 0.35 |
Depreciation | -0.51 | -0.42 | -0.34 | -0.13 |
Tax paid | -0.36 | -0.18 | -0.18 | -0.09 |
Working capital | 1.08 | 1.29 | 1.99 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.22 | 16.02 | 88.81 | |
Op profit growth | 74.85 | 5.87 | 94.57 | |
EBIT growth | 101.4 | -1.11 | 66.42 | |
Net profit growth | 113.25 | -11.11 | 103.32 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,161.9 | 149.54 | 1,12,953.74 | 177.39 | 0.13 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,008.55 | 77.73 | 1,00,772.2 | 333.4 | 0.4 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 748.45 | 440.26 | 56,504.84 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 1,871.4 | 88.69 | 38,244.08 | 159.98 | 0.24 | 919.03 | 106.95 |
Global Health Ltd MEDANTA | 1,163 | 62.66 | 31,236.71 | 93.41 | 0.04 | 802.87 | 130.22 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Arjan Lalchandani
Whole Time Director & CEO
Mohit Lalchandani
Executive Director & CFO
Anchal Gupta
Independent Director
Rajiv Handa
Independent Director
Prakash Jhuraney
Non Executive Director
Swati Chandra
M-20 Basement,
Greater Kailash-1,
New Delhi - 110048
Tel: 91-11-49057058
Website: -
Email: info@lalchandanipathlab.com
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: investor@cameoindia.com
Summary
Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership F...
Read More
Reports by Dr Lalchandani Labs Ltd
What is the Dr Lalchandani Labs Ltd share price today?
What is the Market Cap of Dr Lalchandani Labs Ltd?
What is the PE and PB ratio of Dr Lalchandani Labs Ltd?
What is the 52 Week High and Low of Dr Lalchandani Labs Ltd?
What is the CAGR of Dr Lalchandani Labs Ltd?
What is the shareholding pattern of Dr Lalchandani Labs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.